400858-39-1

Basic information

• Product Name: [(4-(DIMETHYLAMINO)PHENYL)METHYL](4-ISOPROPYLPHENYL)AMINE
• Synonyms: [(4-(DIMETHYLAMINO)PHENYL)METHYL](4-ISOPROPYLPHENYL)AMINE;N-(4-(Dimethylamino)benzyl)-4-isopropylbenzenamine
• CAS NO: 400858-39-1
• Molecular Formula: C₁₈H₂₄N₂
• Molecular Weight: 268.4
• Mol File: 400858-39-1.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: [(4-(DIMETHYLAMINO)PHENYL)METHYL](4-ISOPROPYLPHENYL)AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: [(4-(DIMETHYLAMINO)PHENYL)METHYL](4-ISOPROPYLPHENYL)AMINE(400858-39-1)
• EPA Substance Registry System: [(4-(DIMETHYLAMINO)PHENYL)METHYL](4-ISOPROPYLPHENYL)AMINE(400858-39-1)

Safety Data

• Hazardous Substances Data: 400858-39-1(Hazardous Substances Data)

Usage

General Description

The chemical compound [(4-(dimethylamino)phenyl)methyl](4-isopropylphenyl)amine is a tertiary amine with two aromatic rings and a dimethylamino group. It is commonly used as a precursor in the synthesis of other organic compounds and can also exhibit biological activity in certain contexts. This chemical is typically handled and stored with care due to potential hazards and should be used in a controlled manner by individuals with appropriate training and safety measures in place.

Upstream product

• 99-88-7 4-Isopropylaniline 
• 100-10-7 4-dimethylamino-benzaldehyde 

Downstream Products

• 610794-11-1 5-isopropyl-1-methyl-1H-indazole-4-carboxylic acid (4-di-methylamino-benzyl)-(4-isopropyl-phenyl)-amide 
• 610794-12-2 5-isopropyl-1-methyl-1H-benzoimidazole-4-carboxylic acid (4-dimethylamino-benzyl)-(4-isopropyl-phenyl)-amide 

Relevant articles and documents

Synthesis method of C5a receptor antagonist W-54011

The invention discloses a synthesis method of a C5a receptor antagonist W-54011. The synthesis method comprises the following steps: performing Wittig reaction, demethylation, enol interconversion, oxidation and the like to obtain 7-methoxy-1,2,3,4-tetrah

Novel 3-substituted urea derivatives and medicinal use thereof

The present invention relates to a urea derivative of the formula (1) wherein each symbol is as described in the specification, a pharmaceutically acceptable salt thereof and pharmaceutical use thereof. The compound of the present invention has a C5a receptor antagonistic action and is useful as an agent for the prophylaxis or treatment of diseases or syndromes due to inflammation caused by C5a [e.g., autoimmune diseases such as rheumatism, systemic lupus erythematosus and the like, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergic diseases such as asthma and the like, atherosclerosis, cardiac infarction, brain infarction, psoriasis, Alzheimer's disease and serious organ injury (e.g., pneumonia, nephritis, hepatitis, pancreatitis and the like) due to activation of leukocytes caused by ischemia, trauma, burn, surgical invasion and the like]. In addition, it is useful as an agent for the prophylaxis or treatment of infectious diseases caused by bacteria or virus that invades via a C5a receptor.